ABSTRACT: A major challenge in systems biology is to evaluate the feasibility of a biological research project prior to its realization. Since experiments are animals-, cost-and time-consuming, approaches allowing researchers to discriminate alternative hypotheses with a minimal set of experiments are highly desirable. Given a null hypothesis and alternative model, as well as laboratory constraints like observable players, sample size, noise level, and stimulation options, we suggest a method to obtain a list of required experiments in order to significantly reject the null hypothesis model M 0 if a specified alternative model M A is realized. For this purpose, we estimate the power to detect a violation of M 0 by means of Monte Carlo simulations. Iteratively, the power is maximized over all feasible stimulations of the system using multi-experiment fitting, leading to an optimal combination of experimental settings to discriminate the null hypothesis and alternative model. We prove the importance of simultaneous modeling of combined experiments with quantitative, highly sampled in vivo measurements from the Jak/STAT5 signaling pathway in fibroblasts, stimulated with erythropoietin (Epo). Afterwards we apply the presented iterative experimental design approach to the Jak/STAT3 pathway of primary hepatocytes stimulated with IL-6. Our approach offers the possibility of deciding which scientific questions can be answered based on existing laboratory constraints. To be able to concentrate on feasible questions on account of inexpensive computational simulations yields not only enormous cost and time saving, but also helps to specify realizable, systematic research projects in advance.
INTRODUCTION
Mathematical modeling of cellular processes deepens the functional understanding of biochemical interaction at the microbiological level. [1] [2] [3] [4] [5] However, successful modeling requires high-quality time-resolved quantitative measurements of protein concentrations, which are still difficult to obtain. 6, 7 Hence, for a given noise level and set of observable proteins, the question arises as to which biological hypotheses can be investigated with a reasonable effort. Several methods were suggested to improve the experimental setting in order to optimize the estimation of model parameters. 8, 9 We developed an experimental design approach which suggests an optimal set of required experiments in order to discriminate competing biological hypotheses for given laboratory constraints.
METHODS

Statistical Background: Hypothesis Testing
According to the Neyman-Pearson paradigm, a test statistic T(x) with sample values x can be used to decide whether or not to reject a null hypothesis H 0 in favor of an alternative H A . 10, 11 The sets of values of T for which H 0 is accepted is called the acceptance region or confidence interval with size of 1 − ␣ and those for which H 0 is rejected are called the rejection region of the test. The critical value determines the border between the two regions. In applying the paradigm, a type 1 error (i.e., a false positive event) occurs when H 0 is rejected although it is true. Its probability is designated by ␣. Type 2 errors (i.e., false negative events) occur when H 0 is accepted although it is false. Its probability is ␤. The power of the test is defined as the probability that H 0 is rejected when it is false and equals 1 − ␤. An ideal test would have ␣ = ␤ = 0. Hence, by designing optimal experiments we try to minimize the overlap between null and alternative distributions in order to improve the model discrimination power. The interpretation of a test is as follows: If H 0 is not rejected, it is either really true or the test had no power to detect the violation. Otherwise, if H 0 is rejected, one can only conclude that H 0 is not true, but the validity of the alternative is not proved.
The Jak/STAT3 Signaling Pathway
We exemplify our approach to the IL-6/Jak/STAT3 signaling pathway of primary hepatocytes. The null hypothesis model M0 is depicted in FIGURE 1: The gp130 receptor gets activated via IL-6 ligands and phosphorylates STAT3 monomers. Two pSTAT3 molecules build dimers, are phosphorylated a second time, and enter the nucleus, where they act as transcription factors before FIGURE 1. Null-hypothesis and alternative models of the Jak/STAT3 pathway. Under the null hypothesis, the gp130 receptor is activated via IL-6 and phosphorylates STAT3 monomers. Two pSTAT3 molecules build dimers, get phosphorylated a second time, and enter the nucleus. where they act as transcription factors before leaving the nucleus. M 1 -M 7 represent possible extensions or modifications of the null hypothesis model. leaving the nucleus again. The corresponding chemical reactions are translated into ordinary differential equations via mass-action kinetics and fitted to quantitative measurements in primary hepatocytes. Discrepancies between model and data and screening of the literature led to several alternative models, M 1 -M 7 . The question arose as to which alternative could be successfully distinguished from the null hypothesis model for a given set of observable proteins and a given noise level.
Laboratory Constraints, Stimulus Control, and System Characteristics
Our iterative experimental design approach requires specification of laboratory constraints, characteristic times, and stimulation doses. Depending on the investigated cell system, technical facilities, and experimental skill, several constraints are formulated:
• maximum number of possible time points per experiment;
• expected measurement noise level;
• set of observable proteins; and • realizable stimulations (e.g., dose responses, pulses, ramps).
These constraints have a strong influence on the optimal combination of experiments and the feasibility of the whole research agenda.
As in control engineering, the properties of a dynamical system can only be characterized satisfactorily if the system can be controlled or stimulated with a variety of different input functions. Oscillating inputs-the most often used input function in control engineering-are currently not applicable to the biological systems. However, continuous, pulsed, and ramped stimulations can be applied. This enhances model selection dramatically if methods for multi-experiment fitting are available.
Different signal transduction pathways may possess a strongly different temporal behavior and may need different stimulation doses. Our approach generates a set of basic stimulation experiments which are scaled in time and dosage to meet a realistic stimulus. Therefore a short, medium, and long time period must be specified and similarly a low, medium, and large stimulation dose.
RESULTS
Improved Model Discrimination through Multi-Experiment Fitting
The enormous increase of model discrimination power by use of multiexperiment fitting is shown for a stimulation experiment with fibroblasts. The cells were stimulated with erythropoietin (Epo) in one experiment continuously over 180 minutes and in a second experiment for only 5 min (FIG. 2A,B) . Three models, M 1 -M 3, with increasing complexity were used to describe the receptor kinetics. Fitting of the simplest model M 1 to the activated receptor time courses shows a strong discrepancy for the continuous stimulation (FIG.  2C) . Model M 2 can describe both data sets separately (FIG. 2E,F) , but only with different, locally fitted parameter values. Since a model should be able to describe a system with the same parameter values for different stimulations, a multi-experiment fit is required where both data sets are fitted simultaneously. Figure 2G and H show that model M 2 is not flexible enough to explain the slow decrease for the continuous stimulation and the fast decrease after the pulsed stimulation at once. Only model M 3, which comprises models M 1 and M 2, can explain the data sets for the identical set of parameters (FIG. 2I, J) .
Chi-Square Test Statistic
The discrepancy between a fitted model and a data set-the goodness-offit-can be quantified by the chi-square value,
for N data points y i measured at x i with standard deviation i and modeled by y(x i ; a 1 , . . ., a M ) with M parameters a j . 12 For a valid model and Gaussian distributed errors, the chi-square values are chi-square distributed with k degrees of freedom with k between N-M and N, depending on the model structure. If the calculated chi-square value is not compliant with the corresponding chi-square distribution, the used model can either be significantly rejected to sufficiently describe the data or the used error model is wrong. Since we are interested in discriminating the null hypothesis model from an alternative one, we simulate data from an alternative model and fit the null hypothesis model to the data. Afterwards, the chi-square value is calculated and compared with the significance level of the corresponding chi-square distribution. The reaction schemes of all models are translated into sets of ordinary differential equations. By means of an implicit Runge-Kutta Fortran integrator the systems are integrated during simulation or fitting. 13 Parameters are adapted during the fitting procedure with the trust-region approach, as implemented in the MATLAB optimization toolbox. [14] [15] [16] [17] [18] All simulations and fits were applied within our new developed modeling framework, PottersWheel.
Iterative Experimental Design
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Application to the Jak/STAT3 Signaling Pathway Alternative M 4 describes a cooperative behavior of the activated receptor. We will determine the optimal experimental design in order to distinguish M 4 from the null-hypothesis M 0 . FIGURE 3A shows the ordered chi-square values for nine different stimulations after one hypothetical experiment. Stimulation 4 yields the highest discrimination power, but does not suffice to reject the wrong null hypothesis. Iterative combination with further stimulations up to four experiments is still not sufficient: M 4 cannot be distinguished from M 0 within four experiments (FIG. 3B, C) . Only by combination of five experiments can a significant rejection be achieved (FIG. 3D) .
CONCLUSION
We presented an approach to iteratively create an optimal set of experiments in order to increase the power to detect a violation of a null hypothesis model when a specific alternative is realized instead. It takes into account cellsystem and laboratory-specific constraints like feasible stimulation types, set of observable proteins, and noise levels. The simultaneous fit of one model to several data sets is a key procedure of our approach. Application to the Jak/STAT3 signaling pathway of primary hepatocytes shows that the question of receptor cooperativity cannot be investigated with less than five optimal combined experiments.
